Hunton Andrews Kurth Represents Paragon Medical in $1.9 Billion Sale to AMETEK

Hunton Andrews Kurth LLP recently represented Paragon Medical ("Paragon”), a global industry leader in highly engineered medical components and instruments and portfolio company of private equity firm American Securities LLC, in its $1.9 billion sale to AMETEK, Inc. (NYSE: AME), a leading global provider of industrial technology solutions.

Paragon provides a diverse, industry-leading product portfolio of world-class solutions to blue-chip and emerging original equipment manufacturers across diverse medical end markets. By leveraging its fully-integrated commercial, operations and organizational infrastructure, Paragon aims to deliver superior performance in product quality, reliability, innovation and customer service.

The Hunton Andrews Kurth team advising on the transaction was led by partners Doug Granger and Austin Maloney, and associates Marissa Rogers and Kelli Rice. The team also included partner John Gary Maynard and associate Matthew Ricciardi for intellectual property, partner Adam Solomon for privacy and cybersecurity, and partner Ryan Glasgow for labor and employment.